ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 185049 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 185049; 2) Community: the network communities that were significantly associated with the response to NSC 185049; 3) Molecule: the relationships between components within communities and NSC 185049; 4) MDR: the compounds that were significantly associated with the NSC 185049.

NSC Compound Enrichment Correlation
NSC 684910 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer B)-, stereoisomer of NSC-684909 0.000288319947507353 0.31042498
NSC 268965 Benzaldehyde, 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]- 0.000374267341249421 0.3336393
NSC 618939 Camptothecin Derivative 0.000374267341249421 0.63178294
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.000374267341249421 0.50746334
NSC 722781 trans-bis(acetato)amminepyridineplatinum(II) 0.000601164336889762 0.36670483
NSC 694509 Null 0.00070132188671658 0.38210679
NSC 682298 Camptothecin Derivative 0.000880521445136051 0.64158156
NSC 52426 Null 0.000931492155975089 0.5669088
NSC 99445 1-.beta.-D-Arabinofuranosylcytosine 5'-phosphate 0.000931492155975089 0.47281121
NSC 132313 Dianhydrogalactitol 0.000931492155975116 0.58222854
Total:47  Current:1    [First] [Prev] [Next] [Last]